http://bmj.com/cgi/content/full/324/7350/1376
| Home | Help | Search/Archive | Feedback | Table of Contents |
|
|
||||||||||
|
|
Ross St C Barnetson
a Department of Dermatology, Royal Prince Alfred Hospital, Camperdown NSW 2050, Australia, b Department of Dermatology, New Children's Hospital, Westmead, Sydney, Australia
Correspondence: R St C Barnetson ross@canc.rpa.cs.nsw.gov.au
| |
Introduction |
|---|
|
|
|---|
Atopic eczema is a common condition that affects more than one in ten
children in developed countries, and the incidence is increasing.
There are probably several reasons for this, including higher
exposure to air pollution, smaller families with less exposure to
infections, more pets, higher maternal age, and a wider range of
foods. There is clearly also an important hereditary component to
atopic eczema. This is complex because not all affected children are
atopic, though the genes implicated in atopy are likely to be
involved, together with others as yet unknown. Atopic eczema usually
presents during the first year of life, and when it is severe it is
extremely disabling. It may also cause major psychological problems.
Most affected children are also allergic to house dust mite, and this
is probably a major cause of exacerbation of the condition. Probably
less than 10% overall have IgE mediated food allergy, but some have
late phase reactions with positive results on patch tests to foods.
| Summary points
|
| |
Methods |
|---|
|
|
|---|
We searched Medline for entries on atopic eczema and atopic dermatitis in
children and adults. We also relied on our personal experience in
treating children with atopic eczema over the past 30 years.
| |
Clinical features |
|---|
|
|
|---|
Atopic eczema is usually the first manifestation of atopy and may coincide with food allergy; asthma often follows, then allergic rhinitis (fig 1).
|
There is a wide spectrum of presentations of atopic eczema, from minimal flexural eczema (fig 2) to erythroderma. The skin of a child with eczema is generally dry. The eczema can occur anywhere, but there are particular patterns that are more common at certain ages. The face is usually the first to be affected (fig 3). In crawling infants the forearms, extensor aspects of the knees, and the ankle flexures are often the most affected. In older children the flexor aspects of the elbows and the knees are mostly affected. The eczema may be moist and weeping or may be thickened (lichenified) and dry. In children with darker skin the rash may have a papular nature. Scratch marks are always seen. The course of the condition fluctuates: causes of exacerbations may be evident but usually are not.
Infective complications are common. Staphylococcal infection may manifest as
typical bullous impetigo or simply as a worsening of the eczema with
increased redness and oozing. Staphylococcal folliculitis may occur
as a result of occlusion from greasy emollients or wet dressings.
Streptococcal infection may manifest as increased redness and erosion
of the skin or as pustular lesions. Atopic children are particularly
prone to severe widespread herpes simplex infections; the spread of
the condition is mainly systemic but the areas most affected are the
areas of active eczema.
| |
Psychological issues |
|---|
|
|
|---|
The child's life is limited by the constraints of care of the skin, which can separate the child from his or her peers.2 This can include sport, swimming, and dietary restrictions. The child feels unattractive and different and may have problems with self image and self confidence.
|
| |
Precipitating factors |
|---|
|
|
|---|
There are several possible precipitating factors.
| Psychological issues
The relationship of the child and the parents may be adversely affected because: The child is not physically attractive Touch, which is so important to bonding, is unpleasant as the skin feels rough The child avoids physical contact because of their dislike of the application of creams and dressings The child uses scratching as a weapon, when crossed or denied something Relationships between parents and within the family become strained because of the amount of attention given to one child |
Inhalant allergens
Most children with eczema are atopic and are therefore allergic to
inhalants such as house dust mite (Dermatophagoides pteronyssinus),
grass pollens, and animal dander. Some children develop eczema on the
face during the pollen season, and many parents report that their
child's eczema is worse after close contact with pets. The highest
proportion of IgE is produced against house dust mite, and this must
be the most important allergen in the exacerbation of eczema.3
House dust mite is present in large numbers in children's beds and as well as causing asthma causes exacerbations of eczema. Several studies have shown that actions to reduce dust mite numbers are associated with amelioration of eczema.4 This is not surprising as in children highly allergic to the mites, skin contact is bound to have a deleterious effect on the eczema. The role of delayed hypersensitivity to house dust mite is also likely to be important. People with atopic eczema have positive results to patch tests5 and positive lymphoproliferative responses to the mite. Unfortunately, in everyday life minimisation of house dust mite in bedding is difficult to achieve.
Food allergy and intolerance
In general, food allergy is caused by immunological mechanisms, food
intolerance is not. Food intolerance is relatively common: certain
chemicals in foods may cause worsening of the eczema
for
example, tartrazine or other colourings in food
by
mechanisms that are unclear.
Food allergy is age dependent. It may be severe in the infant and become less so with age. Allergy to some foods (such as egg and cows' milk) is relatively transient, whereas allergy to peanuts or shellfish may continue throughout life.
|
The association between atopic eczema and food allergy is complex, though it
is usually children with severe atopic eczema who have food allergy.
Probably less than 10% of all children with atopic eczema have IgE
mediated food allergy with angioedema and urticaria, when the
diagnosis is obvious from the immediacy of the symptoms and can be
confirmed by a wheal >5 mm in diameter after a skin prick test. Some
of these children have multiple food allergies. There is no doubt
that IgE mediated food allergy can act as a trigger for exacerbations
of eczema,6 but most parents recognise
the allergy and the food is avoided. What is not clear is the role of
late phase food reactions, which cause exacerbations of the eczema
without urticaria or angioedema. These can be confirmed by atopy
patch tests7 and food provocation tests.
This is receiving increasing attention.
| Food allergy and
atopic eczema
Less than 10% of children with atopic eczema have food allergy or food intolerance as exacerbating factors Food allergy may be IgE mediated, giving an immediate reaction Food allergy may be a late phase reaction, as proved by atopy patch tests Food intolerance to ingested chemicals such as colourings (for example, tartrazine) may occur and are not immunologically mediated Exclusion diets are helpful in a small proportion of children with atopic eczema. |
Irritants
Woollen material in direct contact with the skin is a major irritant.
Shiny nylon materials and some acrylics may irritate, but
cotton-polyester mixtures are usually well tolerated. Soap in excess
and bubble baths excessively dry the skin, and many perfumed and
"medicated" products applied to the skin will cause irritation. Some
of the plant extract preparations favoured by alternative
practitioners act as irritants or allergens and a query about the use
of these should always be part of the history taking.
| |
Management |
|---|
|
|
|---|
Explanation and counselling are a vital part of the successful management of childhood eczema. Parents will have received a barrage of advice from a range of medical, paramedical, and non-medical "experts" and require a clear understanding of the nature of the condition, a long term management plan, and a realistic expectation of the results of treatment.
Terminology is often confusing; the terms atopic eczema and atopic dermatitis are often used synonymously. It is essential to talk in terms of control rather than cure, otherwise parents will search for an end point after which care will no longer be required, and this is an unrealistic expectation. The condition should be explained as a multifactorial disorder, and it must be appreciated that just as there is no "cure" there is no single "cause." Often no explanation can be found for a particular flare up of the condition, and many factors are probably working in combination at all times.
Dealing with dryness
Bath oils and products containing oatmeal are useful and prevent the
drying of the skin that bathing can induce. Bath oils that contain
antiseptic may have added benefit in certain cases but have a
tendency to overdry and sometimes actually irritate the skin. The
child should have either a bath with additive or a short shower. It
is essential to find a suitable moisturiser that can be applied all
over twice a day whether or not there is active eczema. Creams
containing cetomacrogol, emulsifying ointment, and creams or
ointments with lanolin can be used. If a product stings the skin it
must be abandoned. The most likely irritant in emollient creams is
the stabiliser propylene glycol. Products that contain urea almost
always sting broken skin and are unsuitable in these
children.
Use of wet dressings
Wet dressings are useful in children with severe widespread eczema.8
This is essentially an inpatient procedure but can be used for short
periods at home. A water based emollient is applied all over; a
corticosteroid cream (rather than ointment in this case because cream
is more water miscible) is applied to the areas of active eczema. The
creams are covered with a double layer of wrapping, the innermost of
which is wetted with tepid water. The material may be cotton sheeting
covered with a crepe bandage, though an easier alternative is the use
of a double layer of tubular elasticated bandage. The procedure
is repeated three times a day. This treatment is usually effective in
clearing the eczema in three or four days.
Avoidance of allergens
House dust mite is the most important allergen. Avoidance measures
have to be carried out assiduously and must include encasing the
mattress and pillows as well as dealing with the top covers, either
by encasement or by hot (>60°C) washing.
If food allergy is suspected, the child should be referred to a paediatric dietician. In general, it is children with severe atopic eczema who have food allergy or food intolerance. Children with flexural eczema are unlikely to have food allergy, unless the history suggests otherwise.
Topical corticosteroids
It is often necessary to spend some time counselling the parents that
topical steroid preparations used appropriately are safe. The
strength chosen depends on the severity of the eczema and the site
affected. The frequency of application depends on the individual
product.
Topical antibacterials
Staphylococcus aureus is commonly cultured from eczematous
skin, and there may be obvious signs of infection. For localised
infections, fusidic acid ointment may be effective. To prevent
infections it is useful to bathe the child in preparations containing
triclosan9 or benzalkonium chloride.
Topical immunosuppressants
Tacrolimus is a potent immunosuppressive drug used in organ
transplantation. A topical formulation has been shown to be effective
in trials in patients with moderate to severe atopic dermatitis. Two
studies specifically related to childhood eczema have confirmed its
efficacy. 10 11 The
main side effect is a sensation of burning. A concern has been raised
as to whether application to skin exposed to sun could increase the
long term risk of skin cancer.
Pimecrolimus (an ascomycin derivative) is a newer immunosuppressive agent, similar to tacrolimus. Preliminary studies in children look encouraging.12
Oral medications
Immunosuppressive drugs
Severe atopic eczema is a serious condition, with huge loss of
quality of life for the child on a par with juvenile rheumatoid
arthritis. It is therefore essential that such children are treated
adequately.
The use of oral steroids should be avoided because of severe rebound of the eczema on withdrawal, the eczema becoming unstable after several courses, and the long term side effects. There are generally two alternatives for severe eczema, cyclosporin and azathioprine.
Ciclosporin
Recent
studies have confirmed the efficacy of ciclosporin in childhood atopic eczema.
13 14 Regrettably
the improvement is often not maintained after withdrawal of the drug.
Continuous treatment is rarely justified in view of the long term
risks (such as hypertension and renal dysfunction). However, it
has a place as an effective, safe, and well tolerated short term
option for the management of severe refractory disease in children.
| Additional educational
resource
Brehler R, Hildebrand A, Luger T. Recent developments in treatment of atopic eczema. J Am Acad Dermatol 1997;36:983-94 Information for patients National Eczema Society (www.eczema.org). One of the most established organisations dedicated to the needs of people with eczema, dermatitis, and sensitive skin. The website is a good general site with free information for people with eczema and dermatitis. Eczema voice (www.eczemavoice.com). This site was set up by parents of a boy with eczema and provides useful information and support for other parents. Talk eczema (www.talkeczema.com). A free online support service for people with eczema and their families. There is a useful dedicated area for young people. babyworld (www.babyworld.co.uk). Though this is a general site about pregnancy, birth, and babies, it also contains useful information about eczema in babies, with frequently asked questions and shared experiences. |
Azathioprine is a safer drug for long term use, though it does have several side effects, including nausea, fatigue, myalgia, and liver dysfunction. It is used by paediatric dermatologists in the United Kingdom.15 It is essential to assay for thiopurine methyl transferase before treatment starts as children deficient in this enzyme will experience marked bone marrow suppression. In most children it is effective at low dosage. The main long term side effect that could theoretically occur (as with ciclosporin) is the development of lymphoma. The advantage of this drug is that it can be used continuously.
Other possibilities include the leukotriene inhibitors zafirlukast16 and montelukast,17 given orally. Chinese herbal medicines have also been used successfully but are not without danger.18
Antihistamines
Sedating antihistamines such as alimemazine and promethazine given at
bedtime are both useful. The sedation is an important feature of
their antipruritic action. It is still debatable whether non-sedating
antihistamines such as cetirizine and loratadine are useful because
generally the role of histamine in eczema is somewhat limited.
However, a large study of the use of cetirizine in adults with atopic
eczema showed a significant reduction of clinical manifestations in
those treated.19
| |
Footnotes |
|---|
Competing interests: None declared.
| |
References |
|---|
|
|
|---|
| 1. | Holgate ST, Church MK, eds. Allergy. London: Gower Medical Publishing, 1993. |
| 2. | Howlett S. Emotional dysfunction, child-family relationships and childhood atopic dermatitis. Br J Dermatol 1999; 140: 381-384[Medline]. |
| 3. | Barnetson RS, Wright AL, Benton EC. IgE-mediated allergy in adults with severe atopic eczema. Clin Exp Allergy 1989; 19: 321-325[Medline]. |
| 4. | Tan BB, Weald D, Strickland I, Friedmann PS. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 1996; 347: 15-18[Medline]. |
| 5. | Mitchell EB, Crow J, Chapman MD, Jouhal SS, Pope FM, Platts-Mills T. Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet 1982; i: 127-130. |
| 6. | Eigenmann PA, Sicherer SH, Borkowski TA, Cohen BA, Sampson HA. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 1998; 101: E8. |
| 7. | Roehr CC, Reibel S, Ziegert M, Sommerfield C, Wahn U, Niggemann B. Atopy patch tests, together with determination of specific IgE levels, reduce the need for oral food challenges in children with atopic dermatitis. J Allergy Clin Immunol 2001; 107: 548-553[Medline]. |
| 8. | Goodyear HM, Spowart K, Harper JI. `Wet-wrap' dressings for the treatment of atopic eczema in children. Br J Dermatol 1991; 125: 604[Medline]. |
| 9. | Sporik R, Kemp AS. Topical triclosan treatment of atopic dermatitis. J Allergy Clin Immunol 1997; 99: 861. |
| 10. | Boguniewicz M, Fiedler VC, Raimer S, Lawrence ID, Leung DY, Hanifin JM. A randomized, vehicle-controlled trial of tacrolimus ointment for the treatment of atopic dermatitis in children. J Allergy Clin Immunol 1998; 102: 637-644[Medline]. |
| 11. | Kang S, Lucky AW, Pariser D, Lawrence I, Hanifin JM. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001; 44(suppl 1): S58-S64[Medline]. |
| 12. | Harper J, Green A, Scott G, Gruendl E, Dorobek B, Cardno M, Burtin P. First experience of topical SDZ ASM 981 in children with atopic dermatitis. Br J Dermatol 2001; 144: 781-787[Medline]. |
| 13. | Berth-Jones J, Finlay AY, Zaki I, Tan B, Goodyear H, Lewis-Jones S, et al. Cyclosporine in severe atopic dermatitis: a multicenter study. J Am Acad Dermatol 1996; 34: 1016-1021[Medline]. |
| 14. | Harper JI, Berth-Jones J, Camp RDR, Dillon MJ, Finlay AY, Holden CA, et al. Cyclosporin for atopic dermatitis in children. Dermatology 2001; 203: 3-6[Medline]. |
| 15. | Murphy LA, Atherton DJ. Azathioprine in severe childhood eczema: value of TPMT as a predictor of outcome and safety in treatment. Br J Dermatol 2001; 144: 927. |
| 16. | Carucci JA, Washenik K, Weinstein A, Shupack J, Cohen DE. The leucotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis. Arch Dermatol 1998; 134: 785-786[Medline]. |
| 17. | Pei AY, Chan HH, Leung TF. Montelukast in the treatment of children with moderate-to-severe atopic dermatitis: a pilot study. Pediatr Allergy Immunol 2001; 12: 154-158[Medline]. |
| 18. | Graham-Brown R. Toxicity of Chinese herbal remedies. Lancet 1992; 340: 673-674[Medline]. |
| 19. | Hannuksela M, Kalimo K, Lammintausta K, Mattila T, Turjanmaa K, Varjonen E, et al. Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults. Ann Allergy 1993; 70: 127-133[Medline]. |
|
|
||||||||||
|
|
Read all Rapid Responses
| Home | Help | Search/Archive | Feedback | Table of Contents |
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.